Modeling human disease using organotypic cultures

Pawel J Schweiger; Kim B Jensen

doi:10.1016/j.ceb.2016.07.003

Modeling human disease using organotypic cultures

34 Citations (Scopus)

Abstract

Reliable disease models are needed in order to improve quality of healthcare. This includes gaining better understanding of disease mechanisms, developing new therapeutic interventions and personalizing treatment. Up-to-date, the majority of our knowledge about disease states comes from in vivo animal models and in vitro cell culture systems. However, it has been exceedingly difficult to model disease at the tissue level. Since recently, the gap between cell line studies and in vivo modeling has been narrowing thanks to progress in biomaterials and stem cell research. Development of reliable 3D culture systems has enabled a rapid expansion of sophisticated in vitro models. Here we focus on some of the latest advances and future perspectives in 3D organoids for human disease modeling.

Original language	English
Journal	Current Opinion in Cell Biology
Volume	43
Pages (from-to)	22-29
Number of pages	8
ISSN	0955-0674
DOIs	https://doi.org/10.1016/j.ceb.2016.07.003
Publication status	Published - 1 Dec 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ceb.2016.07.003

Cite this

@article{7e66b520f4584ab887437c7c7bce8f39,

title = "Modeling human disease using organotypic cultures",

abstract = "Reliable disease models are needed in order to improve quality of healthcare. This includes gaining better understanding of disease mechanisms, developing new therapeutic interventions and personalizing treatment. Up-to-date, the majority of our knowledge about disease states comes from in vivo animal models and in vitro cell culture systems. However, it has been exceedingly difficult to model disease at the tissue level. Since recently, the gap between cell line studies and in vivo modeling has been narrowing thanks to progress in biomaterials and stem cell research. Development of reliable 3D culture systems has enabled a rapid expansion of sophisticated in vitro models. Here we focus on some of the latest advances and future perspectives in 3D organoids for human disease modeling.",

author = "Schweiger, {Pawel J} and Jensen, {Kim B}",

note = "Copyright {\textcopyright} 2016. Published by Elsevier Ltd.",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.ceb.2016.07.003",

language = "English",

volume = "43",

pages = "22--29",

journal = "Current Opinion in Cell Biology",

issn = "0955-0674",

publisher = "Elsevier Ltd. * Current Opinion Journals",

}

TY - JOUR

T1 - Modeling human disease using organotypic cultures

AU - Schweiger, Pawel J

AU - Jensen, Kim B

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Reliable disease models are needed in order to improve quality of healthcare. This includes gaining better understanding of disease mechanisms, developing new therapeutic interventions and personalizing treatment. Up-to-date, the majority of our knowledge about disease states comes from in vivo animal models and in vitro cell culture systems. However, it has been exceedingly difficult to model disease at the tissue level. Since recently, the gap between cell line studies and in vivo modeling has been narrowing thanks to progress in biomaterials and stem cell research. Development of reliable 3D culture systems has enabled a rapid expansion of sophisticated in vitro models. Here we focus on some of the latest advances and future perspectives in 3D organoids for human disease modeling.

AB - Reliable disease models are needed in order to improve quality of healthcare. This includes gaining better understanding of disease mechanisms, developing new therapeutic interventions and personalizing treatment. Up-to-date, the majority of our knowledge about disease states comes from in vivo animal models and in vitro cell culture systems. However, it has been exceedingly difficult to model disease at the tissue level. Since recently, the gap between cell line studies and in vivo modeling has been narrowing thanks to progress in biomaterials and stem cell research. Development of reliable 3D culture systems has enabled a rapid expansion of sophisticated in vitro models. Here we focus on some of the latest advances and future perspectives in 3D organoids for human disease modeling.

U2 - 10.1016/j.ceb.2016.07.003

DO - 10.1016/j.ceb.2016.07.003

M3 - Journal article

C2 - 27474805

SN - 0955-0674

VL - 43

SP - 22

EP - 29

JO - Current Opinion in Cell Biology

JF - Current Opinion in Cell Biology

ER -

Modeling human disease using organotypic cultures

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this